Publication Author: Chapko_Michael
-
1-year risk-adjusted mortality and costs of percutaneous coronary intervention in the Veterans Health Administration: insights from the VA CART Program.
Ho PM, O’Donnell CI, Bradley SM, Grunwald GK, Helfrich C, Chapko M, Liu CF, Maddox TM, Tsai TT, Jesse RL, Fihn SD, Rumsfeld JS. 1-Year Risk-Adjusted Mortality and Costs of Percutaneous Coronary Intervention in the Veterans Health Administration: Insights
rakerr2
-
Access to multiple sclerosis specialty care.
Turner AP, Chapko MK, Yanez D, Leipertz SL, Sloan AP, Whitham RH, Haselkorn JK. Access to multiple sclerosis specialty care. PM R. 2013 Dec;5(12):1044-50. doi: 10.1016/j.pmrj.2013.07.009. Epub 2013 Aug 3.
rakerr2
-
A feasibility study of caregiver-provided massage as supportive care for Veterans with cancer.
Kozak L, Vig E, Simons C, Eugenio E, Collinge W, Chapko M. A feasibility study of caregiver-provided massage as supportive care for Veterans with cancer. J Support Oncol. 2013 Sep;11(3):133-43.
rakerr2
-
Costs of second allogeneic hematopoietic cell transplantation.
Khera N, Storer B, Sandmaier BM, Chapko MK, Lee SJ. Costs of second allogeneic hematopoietic cell transplantation. Transplantation. 2013 Jul 15;96(1):108-15. doi: 10.1097/TP.0b013e318294caf1.
rakerr2
-
Cost-effective diagnostic strategies in patients with a high, intermediate, or low clinical probability of pulmonary embolism.
Lee JA, Zierler BK, Liu CF, Chapko MK. Cost-effective diagnostic strategies in patients with a high, intermediate, or low clinical probability of pulmonary embolism. Vasc Endovascular Surg. 2011 Feb;45(2):113-21. Epub 2010 Aug 31.
rakerr2
-
Importance of health system context for evaluating utilization patterns across systems.
Burgess JF Jr, Maciejewski ML, Bryson CL, Chapko M, Fortney JC, Perkins M, Sharp ND, Liu CF. Importance of health system context for evaluating utilization patterns across systems. Health Econ. 2011 Feb;20(2):239-51.
rakerr2
-
Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication.
Beste LA, Ioannou GN, Larson MS, Chapko M, Dominitz JA. Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication. Clin Gastroenterol Hepatol. 2010 Nov;8(11):972-8. Epub 2010 Aug 6.
rakerr2
-
Use of outpatient care in Veterans Health Administration and Medicare among veterans receiving primary care in community-based and hospital outpatient clinics.
Liu CF, Chapko M, Bryson CL, Burgess JF Jr, Fortney JC, Perkins M, Sharp ND, Maciejewski ML. Use of outpatient care in Veterans Health Administration and Medicare among veterans receiving primary care in community-based and hospital outpatient clinics. He
rakerr2
-
Long-term effectiveness of screening for hearing loss: the screening for auditory impairment–which hearing assessment test (SAI-WHAT) randomized trial.
Yueh B, Collins MP, Souza PE, Boyko EJ, Loovis CF, Heagerty PJ, Liu CF, Hedrick SC. Long-term effectiveness of screening for hearing loss: the screening for auditory impairment–which hearing assessment test (SAI-WHAT) randomized trial. J Am Geriatr Soc.
rakerr2
-
Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
Chapko MK, Yee HS, Monto A, Dominitz JA. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C. Vaccine. 2010 Feb 17;28(7):1726-31. Epub 2009 Dec 29.
rakerr2